描述
is a sterile injectable form of NADP, a critical coenzyme involved in redox reactions across metabolic pathways. Each syringe contains 5?mg of high-purity nicotinamide adenine dinucleotide diphosphate, supporting advanced laboratory research in cellular metabolism, oxidative stress, enzymology, and metabolic profiling.
Formulated by Kaifeng Kangnuo Pharmaceutical Co., Ltd., EnAidi® is officially approved in China under NMPA H41024721, product code 86903134000444. Supplied in 10 sterile ampoules per box. This research-grade injection is ideal for in vitro enzymatic assays and in vivo metabolism models.
?? For laboratory research use only. Not for diagnostic, clinical, or veterinary applications.
Product Specifications
Parameter | Details |
---|---|
Product Name | Coenzyme I for Injection (NAD+) |
Generic Name | Nicotinamide Adenine Dinucleotide Diphosphate (NADP) Injection |
CAS Number | 53?84?9 |
Molecular Formula | C21H27N7O14P2 |
Molecular Weight | ~663.4?g/mol |
Dosage Form | Sterile injection (ampoule) |
Strength | 5?mg per syringe |
Quantity | 10 syringes per box |
Approval Number | H41024721 (China NMPA) |
Product Code | 86903134000444 |
Manufacturer | Kaifeng Kangnuo Pharmaceutical Co., Ltd. |
Intended Use | Laboratory research only |
Storage Conditions | Store at 2–8?°C, protect from light |
Barcode | 86903134000444 |
Mechanism & Research Applications
Coenzyme I (NADP) functions as a coenzyme for dehydrogenases like lactate dehydrogenase and glyceraldehyde-3-phosphate dehydrogenase, facilitating hydride transfer in energy metabolism .
Research applications include:
-
NADP/NADPH dynamics in metabolic flux
-
Oxidative stress and antioxidant enzyme assays
-
In vitro enzyme kinetics and pathway mapping
-
Cellular redox state studies
-
Preclinical metabolic disorder modeling
Observed Effects & Research Notes
-
Activates NADP-dependent enzymes and redox reactions
-
Enhances NADP levels in in vitro systems
-
Likely safe in small research doses; follow biosafety protocols
Safety & Handling Guidelines
-
Use Restriction: Lab research use only; not for clinical or veterinary application
-
Equipment: Use PPE—gloves, lab coat, goggles
-
Storage: Keep between 2–8?°C; avoid freezing and light exposure
-
Disposal: Treat as biohazard; follow institutional and environmental protocols
Core illustrate
This product is a research-grade Coenzyme I (NADP) injection, also known as nicotinamide adenine dinucleotide phosphate injection, manufactured by Kaifeng Kangnuo Pharmaceutical Co., Ltd. It is commonly referred to as EnAidi® injection and is approved under NMPA H41024721.
It is ideal for laboratory studies involving cellular energy metabolism, oxidative stress, and NADP/NADPH enzyme systems. Researchers looking for NADP injectable reagents or coenzymes for redox biology and enzymatic assays will find this product highly suitable.
Wholesale and retail options are supported for researchers and institutions conducting experiments on enzyme kinetics, metabolic regulation, or redox homeostasis.
Research Use Disclaimer
This product is intended strictly for laboratory research use only. It is not approved for therapeutic, diagnostic, clinical, or veterinary applications. Misuse may cause serious health or legal risks. Handle according to institutional biosafety standards and local regulations.
tshir –
Good product quality, thank you!